https://scholars.lib.ntu.edu.tw/handle/123456789/506318
標題: | Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics | 作者: | Hsieh C.-H. Hsieh Y.-J. Liu C.-Y. Tai H.-C. Huang Y.-C. Shueng P.-W. Wu L.-J. LI-YING WANG Tsai T.-H. Chen Y.-J. |
公開日期: | 2010 | 卷: | 8 | 起(迄)頁: | 29 | 來源出版物: | Journal of Translational Medicine | 摘要: | Background: Concurrent chemoradiation with 5-fluorouracil (5-FU) is widely accepted for treatment of abdominal malignancy. Nonetheless, the interactions between radiation and 5-FU remain unclear. We evaluated the influence of abdominal irradiation on the pharmacokinetics of 5-FU in rats.Methods: The radiation dose distributions of cholangiocarcinoma patients were determined for the low dose areas, which are generously deposited around the intrahepatic target volume. Then, corresponding single-fraction radiation was delivered to the whole abdomen of Sprague-Dawley rats from a linear accelerator after computerized tomography-based planning. 5-FU at 100 mg/kg was intravenously infused 24 hours after radiation. A high-performance liquid chromatography system equipped with a UV detector was used to measure 5-FU in the blood. Ultrafiltration was used to measure protein-unbound 5-FU.Results: Radiation at 2 Gy, simulating the daily human treatment dose, reduced the area under the plasma concentration vs. time curve (AUC) of 5-FU by 31.7% compared to non-irradiated controls. This was accompanied by a reduction in mean residence time and incremental total plasma clearance values, and volume of distribution at steady state. Intriguingly, low dose radiation at 0.5 Gy, representing a dose deposited in the generous, off-target area in clinical practice, resulted in a similar pharmacokinetic profile, with a 21.4% reduction in the AUC. This effect was independent of protein binding capacity.Conclusions: Abdominal irradiation appears to significantly modulate the systemic pharmacokinetics of 5-FU at both the dose level for target treatment and off-target areas. This unexpected and unwanted influence is worthy of further investigation and might need to be considered in clinical practice. ? 2010 Hsieh et al; licensee BioMed Central Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952302042&doi=10.1186%2f1479-5876-8-29&partnerID=40&md5=2205e104e626bed276744f20b515098e https://scholars.lib.ntu.edu.tw/handle/123456789/506318 |
ISSN: | 1479-5876 | DOI: | 10.1186/1479-5876-8-29 | SDG/關鍵字: | fluorouracil; antineoplastic antimetabolite; abdominal radiotherapy; animal experiment; area under the curve; article; controlled study; drug blood level; drug clearance; drug distribution; drug elimination; drug half life; drug protein binding; human; nonhuman; radiation dose; radiation dose distribution; rat; tomotherapy; abdominal tumor; animal; bile duct carcinoma; dose response; drug effect; liver; male; metabolism; multimodality cancer therapy; radiation exposure; radiation response; Sprague Dawley rat; Abdominal Neoplasms; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Cholangiocarcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorouracil; Humans; Liver; Male; Rats; Rats, Sprague-Dawley |
顯示於: | 物理治療學系所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。